Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The quick ratio (acid-test) is N/A as of Tuesday, October 6, 2026.
QUICK RATIO (ACID-TEST)
N/A
Latigo Biotherapeutics Inc.
Market Cap
$1.01B
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$997.80M
Quick Ratio (Acid-Test)
3.76
TTM Avg
1.39
3Y Avg
1.76
5Y Avg
2.46
Market Cap
$998.93M
Quick Ratio (Acid-Test)
5.35
TTM Avg
6.89
3Y Avg
6.87
5Y Avg
8.97
Market Cap
$997.28M
Quick Ratio (Acid-Test)
16.33
TTM Avg
11.68
3Y Avg
16.13
5Y Avg
16.13
Market Cap
$1.00B
Quick Ratio (Acid-Test)
15.08
TTM Avg
22.50
3Y Avg
27.08
5Y Avg
27.08
Market Cap
$990.99M
Quick Ratio (Acid-Test)
3.94
TTM Avg
2.64
3Y Avg
3.04
5Y Avg
2.66
Market Cap
$1.02B
Quick Ratio (Acid-Test)
1.44
TTM Avg
1.13
3Y Avg
1.10
5Y Avg
1.10
Market Cap
$1.03B
Quick Ratio (Acid-Test)
1.98
TTM Avg
1.08
3Y Avg
1.74
5Y Avg
1.96
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Latigo Biotherapeutics Inc. (LTGO) | $1.01B | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $997.80M | 3.76 | 1.39 | 1.76 | 2.46 |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $998.93M | 5.35 | 6.89 | 6.87 | 8.97 |
| Aktis Oncology, Inc. (AKTS)vs › | $997.28M | 16.33 | 11.68 | 16.13 | 16.13 |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $1.00B | 15.08 | 22.50 | 27.08 | 27.08 |
| Pacira BioSciences, Inc. (PCRX)vs › | $990.99M | 3.94 | 2.64 | 3.04 | 2.66 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 1.44 | 1.13 | 1.10 | 1.10 |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | 1.98 | 1.08 | 1.74 | 1.96 |
| Immatics N.V. (IMTX)vs › | $1.04B | 7.54 | 10.49 | 6.85 | 5.34 |
| Kura Oncology, Inc. (KURA)vs › | $963.61M | 4.71 | 7.76 | 11.58 | 15.68 |
Quick Ratio
N/A
Excludes inventory
Current Ratio
N/A
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
